LINTEX
920106
LINGOOD
833284
Ji Yao Holding Group
300108
4
Sino Geophysical
300191
5
Henan Carve Electronics Technology
301182
US Stock MarketDetailed Quotes
ASND Ascendis Pharma A/S
- 153.140
- +0.530+0.35%
Close Feb 27 16:00 ET
- 153.140
- 0.0000.00%
Post 20:01 ET
9.16BMarket Cap-22.55P/E (TTM)
155.040High152.170Low239.85KVolume152.500Open152.610Pre Close36.79MTurnover0.40%Turnover RatioLossP/E (Static)59.84MShares157.37052wk High-83.36P/B9.09BFloat Cap111.09052wk Low--Dividend TTM59.37MShs Float183.980Historical High--Div YieldTTM1.88%Amplitude11.920Historical Low153.382Avg Price1Lot Size
Ascendis Pharma A/S News
Ascendis Pharma A/S | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | 144: Notice of proposed sale of securities pursuant to Rule 144
Ascendis Pharma A/S | SCHEDULE 13G/A: Others
Ascendis Pharma A/S | 20-F: FY2024 Annual Report
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | SCHEDULE 13G/A: Others
Ascendis Pharma A/S | SCHEDULE 13G/A: Others
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ascendis Pharma A/S | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Trending Stocks
Discussing
Widespread uptick! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. Chinese stocks l
Moomoo News Global
Feb 24 22:30
Chinese Stocks' Wild Rally Hits Pause? Wall Street Still Bets Big on Favorites